Journal of Pediatric Neurology 2010; 08(04): 375-379
DOI: 10.3233/JPN-2010-0414
Georg Thieme Verlag KG Stuttgart – New York

Levels of leptin, insulin, IGF-I, IGFBP-3, IL-6 and IL-8 in sera of patients with muscular dystrophy and mitochondrial encephalomyopathy

Authors

  • Manuel Castro-Gago

    a   Department of Pediatrics, Neuropediatrics Service, Hospital Clínico Universitario, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Carmen Gómez-Lado

    a   Department of Pediatrics, Neuropediatrics Service, Hospital Clínico Universitario, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  • María Inés Novo-Rodríguez

    a   Department of Pediatrics, Neuropediatrics Service, Hospital Clínico Universitario, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Jesús Eirís-Puñal

    a   Department of Pediatrics, Neuropediatrics Service, Hospital Clínico Universitario, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Javier Rodríguez-García

    b   Central Laboratory Service, Hospital Clínico Universitario, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Santiago Rodríguez-Segade

    b   Central Laboratory Service, Hospital Clínico Universitario, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain

Subject Editor:
Further Information

Publication History

08 October 2009

03 December 2009

Publication Date:
30 July 2015 (online)

Abstract

There is evidence that muscle forms part of endocrine networks, secreting/or responding to circulating agents such as leptin and interleukin-6 as well as the classical hormone insulin. To gain further insight into the possible role of these hormones and cytokines in muscle degenerative diseases, we investigate their concentrations in sera from patients with muscular dystrophy and mitochondrial encephalomyopathy. In 13 patients with muscular dystrophy, in eight patients with mitochondrial encephalomyopathy, and in 8 age-matched healthy control subjects, the concentrations of leptin, insulin, insulin-like growth factor I, insulin-like growth factor binding protein-3 (IGFBP-3), interleukin 6 and interleukin 8 in sera were determined. The only statistically significant difference between patient groups and controls was lower IGFBP-3 levels in patients with mitochondrial encephalomyopathy. Save the IGFBP-3, the other hormones and cytokines measured do not appear to be involved in the pathophysiology of these myopathies, at least in an endocrine, as opposed to a para-or autocrine, role.